Copyright
©The Author(s) 2024.
World J Meta-Anal. Dec 18, 2024; 12(4): 96981
Published online Dec 18, 2024. doi: 10.13105/wjma.v12.i4.96981
Published online Dec 18, 2024. doi: 10.13105/wjma.v12.i4.96981
Table 3 Results of the Tampa Scale of Kinesiophobia scale of the studies
Ref. | Baseline MV (SD) | Intermediate measurement, MV (SD) | End of intervention, MV (SD) | Follow-up, MV (SD) | P value, baseline-finish | P value, baseline–follow up |
Akodu et al[29], 2021 | CSPSE: 40.17 ± 3.16 PE: 40.82 ± 2.44 DIE: 39.73 ± 2.28 | 4th week CSPSE: 37.38 ± 3.20 PE: 39.46 ± 1.85 DIE: 39.79 ± 2.19 | 8th week CSPSE: 33.17 ± 3.27 PE: 37.27 ± 1.95 DIE: 38.36 ± 3.36 | - | P = 0.072 P = 0.001 | - |
Cruz-Díaz et al[16], 2018 | Mean value PG: 34.50 CG: 34.00 | 6 th week Mean value PG: 27.50 CG: 33.00 | 12 th week Mean value PG: 27.50 CG: 32.50 | - | P < 0.001 | - |
Cruz-Díaz et al[30], 2017 | PMG: 34.52 ± 4.14 PEG: 36.50 ± 3.92 CG: 33.90 ± 4.23 | 6th week PMG: 32.23 ± 3.06 PEG: 34.08 ± 4.1 CG: 34.26 ± 3.96 | 12th week PMG: 31.73 ± 3.24 PEG: 32.00 ± 3.56 CG: 34.10 ± 4.04 | - | P < 0.05 | - |
da Luz et al[31], 2014 | PMG: 39.7 ± 8.1 PEG: 39.6 ± 8.0 | - | 6th week PMG: 35.3 ± 6.6 PEG: 34.1 ± 7.8 | 6th month PMG: 40.0 ± 9.9 PEG: 34.9 ± 7.9 | P > 0.05 | P < 0.001 |
Miyamoto et al[32], 2013 | PG: 39.4 ± 6.1 CG: 39.5 ± 7.1 | - | 6th week PG: 36.3 ± 7.4 CG: 38.1 ± 8.3 | 6 th month PG: 38.1 ± 7.2 CG: 38.9 ± 7.3 | P = 0.20 | P = 0.61 |
- Citation: Sivrika A, Sivrika P, Morakis A, Lamnisos D, Georgoudis G, Stasinopoulos D. Is Pilates an effective tool for the management of kinesiophobia in musculoskeletal disorders? World J Meta-Anal 2024; 12(4): 96981
- URL: https://www.wjgnet.com/2308-3840/full/v12/i4/96981.htm
- DOI: https://dx.doi.org/10.13105/wjma.v12.i4.96981